Product
Currency:CNY
2024/H1
Stock NameRevenueRatio
Reagent1.86B84.14%
Instrument274.68M12.45%
Other51.85M2.35%
Maintenance income23.48M1.06%
Other----
Industry
Currency:CNY
2023/FY
Stock NameRevenueRatio
In vitro diagnosis4.37B98.29%
Other76.05M1.71%
Region
Currency:CNY
2024/H1
Stock NameRevenueRatio
Domestic2.08B94.07%
Abroad130.82M5.93%